View Older Stories View More Recent Stories
-
Selkirk Copper Announces Initial Results from the Phase 2 Drill Program and Commencement of Technical Data Collection to Support Planned Feasibility Study
-
Abitibi Metals Appoints Keith Gorman as Chief Financial Officer and Operations Update
-
AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
-
Knight Transportation (KNX) PT Raised to $90 at BofA Securities
-
Northland Starts Granite Ridge Resources (GRNT) at Outperform, 'Deep Discount & Moving to FCF+'
-
Guggenheim Reiterates Neutral Rating on Warner Brothers Discovery (WBD)
-
Vera Therapeutics (VERA) PT Raised to $76 at Guggenheim
-
Canaccord Reiterates Buy Rating on Compass Pathways (CMPS)
-
BTIG Starts Presidio Production (FTW) at Buy
-
Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
-
Spire Global launches ten satellites on SpaceX Transporter-17 mission
-
H.C. Wainwright Reiterates Buy Rating on Titan Mining Corp. (TII)
-
H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)
-
H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
-
H.C. Wainwright Reiterates Buy Rating on MeiraGTx Holdings plc (MGTX)
-
Vera Therapeutics (VERA) PT Raised to $125 at H.C. Wainwright
-
Needham on Amazon.com (AMZN): 'demand for AWS compute remains strong'
-
H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
-
Ambiq Micro Inc (AMBQ) PT Raised to $86 at Northland
-
H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
-
H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
-
Ladenburg Thalmann Assumes PMV Pharmaceuticals Inc. (PMVP) at Buy
-
Needham Reiterates Buy Rating on Veritone (VERI)
-
Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
Mizuho Reiterates Outperform Rating on Fiserv (FISV)
-
GameStop stockholders approve share count increase to 2.5 billion
-
Satellos reports 6-month interim data for DMD drug candidate SAT-3247
-
Perspective Therapeutics names new chief science officer
-
UBS Downgrades Moelis (MC) to Sell
-
Parsons launches AresNXT biometrics platform for security use
-
Bio-Techne expands AI-engineered protein portfolio for cell therapy
-
Trilogy Metals posts wider Q2 loss as permitting advances in Alaska
-
Hyperscale Data holds 2026 revenue guidance at $180M-$200M
-
BNL commits $303 million to build Colorado tech facility
-
Wells Fargo Assumes AT&T (T) at Underweight
-
Akamai named security partner for WWT's AI security framework
-
Wells Fargo Starts Mobility Global (MBGL) at Overweight
-
Wells Fargo Assumes Verizon (VZ) at Equal Weight
-
Wells Fargo Assumes T-Mobile (TMUS) at Equal Weight
-
VinFast partners with Autobrains on autonomous driving tech
-
SambaNova raises $1 billion at $11 billion valuation
-
Deutsche Bank secures Saudi Arabia regional headquarters licence
-
EU aviation agency tells airlines to avoid Iran, Iraq and Lebanon airspace
-
Truist Securities Starts Wynn Resorts Ltd (WYNN) at Buy
-
Apple commits over $30 billion to Broadcom chip deal
-
Boston Scientific (BSX) PT Lowered to $57 at Needham
-
Stocks expected to have increasing option volume: USO CVX XOM OIH PEP DAL MU SNDK WDC INTC
-
Guardian Exploration Mobilizes Crews for 2026 Exploration Program at Mount Cameron Project, Yukon
-
Cantor Fitzgerald Assumes EyePoint Inc. (EYPT) at Overweight
-
Barclays Downgrades Universal Health Services (UHS) to Equalweight
